What does it mean when pathology report says positive margins
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Positive Margins on a Pathology Report
When a pathology report says you have positive margins, it means that cancer cells were found at the edge of the tissue that was removed during surgery. Think of it this way: the surgeon removed a piece of tissue, and when the pathologist examined it under the microscope, they found tumor cells right at the outer boundary of that removed tissue.
Why This Matters
Positive margins suggest that:
- Cancer cells may still be present in the body beyond what was surgically removed
- There's a higher risk that some cancer was left behind in the area where the surgery took place
- Additional treatment or a second surgery may be needed to remove any remaining cancer
This is different from negative margins (also called "clear margins"), which means the surgeon successfully removed the tumor with a border of healthy tissue around it—like a safety zone.
What Typically Happens Next
According to NCCN (National Comprehensive Cancer Network) Guidelines, when positive margins are found, oncologists generally consider:
- Re-excision surgery - Going back in to remove more tissue from that area
- Radiation therapy - To target any remaining cancer cells in that region
- Systemic treatments - Chemotherapy or other drugs to address cancer throughout the body
- Combination approaches - Using multiple treatments together
The specific approach depends on your cancer type, location, and other factors in your case.
Questions to Ask Your Oncologist
Since positive margins require a treatment plan tailored to YOUR situation, ask your doctor:
- What does "positive margin" mean for my specific cancer type and location?
- Do you recommend re-excision surgery, radiation, or another approach?
- How will this change my overall treatment plan?
- What's the goal of the next treatment—to eliminate remaining cancer or reduce recurrence risk?
- What are the potential side effects of the recommended approach?
Getting More Information
The American Cancer Society and NCI (National Cancer Institute) both have detailed resources about surgical margins and what they mean for different cancer types. Your pathology report should also specify which margins were positive (this varies by cancer location), which is important context for your doctor's recommendations.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with diagnosis for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ